Molecular recognition of tachykinin receptor selective agonists: Insights from structural studies

Anjali Ganjiwale, Sudha M. Cowsik

Research output: Contribution to journalArticle

7 Scopus citations


This Review deals essentially with the elucidation of structural features of Tachykinin family of neuropeptides, which are known to interact through three distinct GPCR subtypes, namely NK1 (Neurokinin 1), NK2 (Neurokinin 2) and NK3 (Neurokinin 3) receptors. In mammals, Tachykinins have been shown to elicit a wide array of activities such as powerful vasodilatation, hypertensive action and stimulation of extravascular smooth muscle and are known to be involved in a variety of clinical conditions including chronic pain, Parkinson's disease, Alzheimer's disease, depression, rheumatoid arthritis, irritable bowel syndrome and asthma. This broad spectrum of action of Tachykinins is attributed to the lack of selectivity of tachykinins to their receptors. All tachykinins interact with all the three-receptor subtypes with SP preferring NK1, NKA preferring NK2 and NKB preferring NK3. This lack of specificity can be accounted for by the conformational flexibility of these short, linear peptides. Hence, identification of structural features of the agonists important for receptor binding and biological activity is of great significance in unraveling the molecular mechanisms involved in tachykinin receptor activation and also in rational design of novel therapeutic agents. Understanding structure of the ligand-receptor complex and analysis of topography of the binding pocket of the tachykinin receptor is also crucial in rational design of drugs.

Original languageEnglish
Pages (from-to)2036-2046
Number of pages11
JournalMini-Reviews in Medicinal Chemistry
Issue number14
StatePublished - Dec 1 2013
Externally publishedYes


  • NK1
  • NK2 and NK3 receptors
  • Neurokinin receptor
  • Structure activity relationship
  • Tachykinin

Fingerprint Dive into the research topics of 'Molecular recognition of tachykinin receptor selective agonists: Insights from structural studies'. Together they form a unique fingerprint.

  • Cite this